Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome with various causes that may influence prognosis. Methods and results We extracted the electronic medical records for 2180 consecutive patients hospitalized between 2016 and 2019 for decompensated heart failure. Using a text mining algorithm looking for a left ventricular ejection fraction ≥50% and plasma brain natriuretic peptide level >100 pg/mL, we identified 928 HFpEF patients. We screened for a prevailing cause of HFpEF according to European guidelines and found that 418 (45.0%) patients had secondary HFpEF due to either myocardial ( n = 125, 13.5%) or loading condition abnormalities ( n = 293, 31.5%), while the remaining 510 (55.0%) patients had idiopathic HFpEF. We assessed the association between the causes of HFpEF and survival collected up to 31 December 2020 using Cox proportional hazards analysis. Even though patients with idiopathic HFpEF were older, frequently female, and had frequent co‐morbidities and a higher crude mortality rate compared with secondary HFpEF patients, their prognosis was similar after adjustment for age and sex. Unsupervised clustering analysis revealed three main phenogroups with different distribution of idiopathic vs. secondary HFpEF. The phenogroup with the highest proportion of idiopathic HFpEF (69%) had (i) an excess rate of non‐cardiac co‐morbidities including chronic obstructive pulmonary disease (31%) or obesity (41%) and (ii) a better prognosis compared with the two other phenogroups enriched with secondary HFpEF. Conclusions Aetiological classification provides clinical and prognostic information and may be useful to better decipher the clinical heterogeneity of HFpEF..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
ESC Heart Failure - 9(2022), 1, Seite 519-530 |
| Beteiligte Personen: |
Fayol, Antoine [VerfasserIn] |
|---|
| Anmerkungen: |
© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology |
|---|
| Umfang: |
12 |
|---|
| doi: |
10.1002/ehf2.13717 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY004954696 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY004954696 | ||
| 003 | DE-627 | ||
| 005 | 20230307142515.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230214s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/ehf2.13717 |2 doi | |
| 028 | 5 | 2 | |a EHF2_EHF213717.xml |
| 035 | |a (DE-627)WLY004954696 | ||
| 035 | |a (WILEY)EHF213717 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Fayol, Antoine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction |
| 264 | 1 | |c 2022 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology | ||
| 520 | |a Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome with various causes that may influence prognosis. Methods and results We extracted the electronic medical records for 2180 consecutive patients hospitalized between 2016 and 2019 for decompensated heart failure. Using a text mining algorithm looking for a left ventricular ejection fraction ≥50% and plasma brain natriuretic peptide level >100 pg/mL, we identified 928 HFpEF patients. We screened for a prevailing cause of HFpEF according to European guidelines and found that 418 (45.0%) patients had secondary HFpEF due to either myocardial ( n = 125, 13.5%) or loading condition abnormalities ( n = 293, 31.5%), while the remaining 510 (55.0%) patients had idiopathic HFpEF. We assessed the association between the causes of HFpEF and survival collected up to 31 December 2020 using Cox proportional hazards analysis. Even though patients with idiopathic HFpEF were older, frequently female, and had frequent co‐morbidities and a higher crude mortality rate compared with secondary HFpEF patients, their prognosis was similar after adjustment for age and sex. Unsupervised clustering analysis revealed three main phenogroups with different distribution of idiopathic vs. secondary HFpEF. The phenogroup with the highest proportion of idiopathic HFpEF (69%) had (i) an excess rate of non‐cardiac co‐morbidities including chronic obstructive pulmonary disease (31%) or obesity (41%) and (ii) a better prognosis compared with the two other phenogroups enriched with secondary HFpEF. Conclusions Aetiological classification provides clinical and prognostic information and may be useful to better decipher the clinical heterogeneity of HFpEF. | ||
| 700 | 1 | |a Wack, Maxime |4 aut | |
| 700 | 1 | |a Livrozet, Marine |4 aut | |
| 700 | 1 | |a Carves, Jean‐Baptiste |4 aut | |
| 700 | 1 | |a Domengé, Orianne |4 aut | |
| 700 | 1 | |a Vermersch, Eva |4 aut | |
| 700 | 1 | |a Mirabel, Mariana |4 aut | |
| 700 | 1 | |a Karras, Alexandre |4 aut | |
| 700 | 1 | |a Le Guen, Julien |4 aut | |
| 700 | 1 | |a Blanchard, Anne |4 aut | |
| 700 | 1 | |a Azizi, Michel |4 aut | |
| 700 | 1 | |a Amar, Laurence |4 aut | |
| 700 | 1 | |a Bories, Marie‐Cécile |4 aut | |
| 700 | 1 | |a Mousseaux, Elie |4 aut | |
| 700 | 1 | |a Carette, Claire |4 aut | |
| 700 | 1 | |a Puymirat, Etienne |4 aut | |
| 700 | 1 | |a Hagège, Albert |4 aut | |
| 700 | 1 | |a Jannot, Anne‐Sophie |4 aut | |
| 700 | 1 | |a Hulot, Jean‐Sébastien |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ESC Heart Failure |g 9(2022), 1, Seite 519-530 |w (DE-627)WLY004941543 |x 20555822 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2022 |g number:1 |g pages:519-530 |g extent:12 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2022 |e 1 |h 519-530 |g 12 | ||